Ferrosan Medical Devices is a renowned brand in the medical industry, offering a comprehensive range of innovative products and services. With a long history dating back to 1947, Ferrosan has been developing and manufacturing surgical hemostats, which are widely used by healthcare professionals to control bleeding during surgeries. Their products, sold under the trademarks SURGIFLO™, SPONGOSTAN™, and SURGIFOAM®, are available in over 100 countries, including Europe, Asia Pacific, Latin America, Canada, the Middle East, and Africa.

In addition to hemostatic products, Ferrosan also specializes in producing handheld biopsy devices for breast cancer diagnostics and electronic pumps for the continuous dispensing of medicines. They are committed to providing healthcare professionals globally with innovative therapeutic alternatives that address clinical problems within biosurgery, ultimately enhancing patient outcomes. With a focus on innovation, Ferrosan has a robust pipeline of development projects and invests significantly in expanding its business and entering new markets.

The company prides itself on its full-circle competencies, from identifying user needs to manufacturing the final product. Ferrosan Medical Devices employs 250 people at its headquarters in Soeborg, Denmark, and another 100 employees in Szczecin, Poland. Driven by its vision to create a world where surgeries are performed without interruption or complications, Ferrosan is dedicated to delivering solutions that add clinical value to healthcare professionals.

Their mission is to provide innovative products that effectively stop bleeding and leaks during surgery, contributing to successful clinical outcomes